Slovakia: Difference between revisions

From Beacon
Line 47: Line 47:
== [[hasQoLandPalliativeCareResearch::Quality_of_Life_and_Palliative_Care_Research_(Slovakia)|Quality of Life and Palliative Care Research]] ==
== [[hasQoLandPalliativeCareResearch::Quality_of_Life_and_Palliative_Care_Research_(Slovakia)|Quality of Life and Palliative Care Research]] ==
<div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide">
<div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide">
'''List of Articles:''' Quality of Life [https://pubmed.ncbi.nlm.nih.gov/?term=Quality+of+Life%5BMeSH%5D+AND+Slovakia%5BAffiliation%5D+AND+cancer&filter=pubt.clinicaltrial&filter=pubt.meta-analysis&filter=pubt.randomizedcontrolledtrial&filter=pubt.systematicreview] and Palliative Care [https://pubmed.ncbi.nlm.nih.gov/?term=Palliative+Care%5BMeSH%5D+AND+Slovakia%5BAffiliation%5D+AND+cancer&filter=pubt.clinicaltrial&filter=pubt.meta-analysis&filter=pubt.randomizedcontrolledtrial&filter=pubt.systematicreview].
</div>
</div>

Revision as of 18:40, 23 May 2024

Go back to Cancer Centers list.

Healthcare System

Registries

Electronic Health Records

Latest Policymaking Initiatives

Reports: National Oncology Institute

Sponsor, manager or home institution: Národný Onkologický Inštitútu.

Primary purpose: To function as a clinical-research, academic, and educational platform to support the National Oncology Program in various areas, including epidemiology, science, research, prevention, screening, diagnosis, treatment, and supportive care.

Type of information: The most common cancers; Cancer diseases; Overview of the availability of palliative care in the health system; Number of capacities in palliative care; Availability of original oncology treatment; Cost-effectiveness of colorectal cancer screening; Participation in opportunistic colorectal cancer screening; Number of breast, cervical, colorectal and lung screenings; Rate of participation in screenings; estimated rate of coverage; Share of clinical stages of malignant tumors; Number and percentage of clinical stages of malignant tumors; List of verified screening mammography workplaces; Number of women invited to a screening mammography examination; Relative rate of women's participation in mammography screening; Number of diagnosed malignancies during mammography screening.

Data level: National and regional level.

Access to information: Access annual reports [1]. Screenings information [2]; Epidemiological report of cancer diseases [3].

Report: EU Country Cancer Profile 2023

Cancer-related Patient Associations and Resources

Quality of Life and Palliative Care Research